Wednesday, March 21, 2018 8:45 PM
|
The Vascular Connection to Multiple Sclerosis
HSCT is back in the news, with a recent BBC story on Dr. Burt's new 110 patient study. The study followed RRMS patients for one year and found a reduction in relapses compared to DMTs. But HSCT uses chemo to wipe out immune system, and is only helpful for young, recently diagnosed patients with very inflammatory RRMS. It's important to read beyond the miracle cure headlines. Whenever there is a news story on autologous hematopoietic stem cell transplants (HSCT), I hear about it. Perhaps this also happens to you,...
|